Top Markets
Coin of the day
Qualigen Therapeutics, Inc. Qualigen Therapeutics, Inc.

Qualigen Therapeutics, Inc.

QLGN
Classificação em ações #35381
Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing... Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing groundbreaking treatments for both cancer and infectious diseases. In addition to its developmental pipeline, the company offers FastPack, an efficient system designed for swift diagnostic testing. Its therapeutic candidates currently undergoing development include QN-302, an investigational compound targeting pancreatic ductal adenocarcinoma; QN-247, a DNA-coated gold nanoparticle formulated to combat various types of cancer; and RAS-F, a small-molecule inhibitor designed to block RAS oncogene protein-protein interactions, thereby impeding RAS mutations and suppressing tumor growth. The company is also progressing with the STARS blood cleansing system, an innovative DNA/RNA-based device engineered to purify a patient's bloodstream by eliminating tumor-derived substances and viruses. Founded in 1996, Qualigen Therapeutics, Inc. is headquartered in Carlsbad, California.
Preço da ação
$2.37
Última sincronização: 2025-12-15
Valor de mercado
$3.99M
Variação (1 dia)
-5.58%
Variação (1 ano)
24.74%
País
US
Negociar Qualigen Therapeutics, Inc. (QLGN)

Categoria

Histórico de preços das ações de Qualigen Therapeutics, Inc. (QLGN)
Preço de fecho mais alto: $2.47 em 2025-12-01

Preço de fecho mais baixo: $589.38K em 2015-06-01
Histórico de preços das ações da Qualigen Therapeutics, Inc. de 2015 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 21.69%
2025 -41.50%
2024 -86.58%
2023 -55.56%
2022 -87.61%
2021 -67.06%
2020 -20.04%
2019 -75.35%
2018 -77.36%
2017 -88.49%
2016 37.25%
2015 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE